Sigloy, France

Mark Julien


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Julien: Innovator in Pharmaceutical Composition

Introduction

Mark Julien is a prominent inventor based in Sigloy, France, known for his significant contributions to the field of pharmaceutical sciences. His innovative spirit has led to the development of a unique orodispersible pharmaceutical composition that enhances the administration of agomelatine.

Latest Patents

Mark holds one patent titled "Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine." This invention pertains to a coated solid orodispersible pharmaceutical composition designed for the effective oral, oromucosal, or sublingual delivery of agomelatine, a compound important for the treatment of various mood disorders.

Career Highlights

Throughout his career, Mark has made noteworthy strides in the pharmaceutical industry. Currently, he works at Les Laboratoires Servier, a company renowned for its commitment to advancing healthcare through innovative treatments. His work at Servier emphasizes his dedication to enhancing drug delivery methods and patient care.

Collaborations

In his professional journey, Mark has collaborated with talented individuals such as Jean-Manuel Pean and Francois Tharrault. Together, they have worked on exploring new avenues in pharmaceutical formulations, contributing to breakthroughs that can significantly impact patient treatment protocols.

Conclusion

Mark Julien continues to be a valuable asset in the realm of pharmaceutical innovations. His patented development of an orodispersible composition marks a significant step forward in the effective administration of medications, showcasing the essential role of inventors in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…